Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Drops By 50.0%

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the recipient of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 800 shares, a decrease of 50.0% from the March 31st total of 1,600 shares. Based on an average trading volume of 3,200 shares, the short-interest ratio is currently 0.3 days.

bioAffinity Technologies Stock Performance

NASDAQ:BIAFW remained flat at $0.45 during trading hours on Friday. bioAffinity Technologies has a fifty-two week low of $0.05 and a fifty-two week high of $0.90. The business’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.23.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.